HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Multicenter study for defining the breakpoint for rifampin resistance in Neisseria meningitidis by rpoB sequencing.

Abstract
Identification of clinical isolates of Neisseria meningitidis that are resistant to rifampin is important to avoid prophylaxis failure in contacts of patients, but it is hindered by the absence of a breakpoint for resistance, despite many efforts toward standardization. We examined a large number (n = 392) of clinical meningococcal isolates, spanning 25 years (1984 to 2009), that were collected in 11 European countries, Argentina, and the Central African Republic. The collection comprises all clinical isolates with MICs of > or = 0.25 mg/liter (n = 161) received by the national reference laboratories for meningococci in the participating countries. Representative isolates displaying rifampin MICs of < 0.25 mg/liter were also examined (n = 231). Typing of isolates was performed, and a 660-bp DNA fragment of the rpoB gene was sequenced. Sequences differing by at least one nucleotide were defined as unique rpoB alleles. The geometric mean of the MICs was calculated for isolates displaying the same allele. The clinical isolates displaying rifampin MICs of > 1 mg/liter possessed rpoB alleles with nonsynonymous mutations at four critical amino acid residues, D542, H552, S548, and S557, that were absent in the alleles found in all isolates with MICs of < or = 1 mg/liter. Rifampin-susceptible isolates could be defined as those with MICs of < or = 1 mg/liter. The rpoB allele sequence and isolate data have been incorporated into the PubMLST Neisseria database (http://pubmlst.org/neisseria/). The rifampin-resistant isolates belonged to diverse genetic lineages and were associated with lower levels of bacteremia and inflammatory cytokines in mice. This biological cost may explain the lack of clonal expansion of these isolates.
AuthorsMuhamed-Kheir Taha, Sara Thulin Hedberg, Marek Szatanik, Eva Hong, Corinne Ruckly, Raquel Abad, Sophie Bertrand, Francoise Carion, Heike Claus, Alejandra Corso, Rocío Enríquez, Sigrid Heuberger, Waleria Hryniewicz, Keith A Jolley, Paula Kriz, Marta Mollerach, Martin Musilek, Arianna Neri, Per Olcén, Marina Pana, Anna Skoczynska, Cecilia Sorhouet Pereira, Paola Stefanelli, Georgina Tzanakaki, Magnus Unemo, Julio A Vázquez, Ulrich Vogel, Izabela Wasko
JournalAntimicrobial agents and chemotherapy (Antimicrob Agents Chemother) Vol. 54 Issue 9 Pg. 3651-8 (Sep 2010) ISSN: 1098-6596 [Electronic] United States
PMID20606072 (Publication Type: Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Rifampin
Topics
  • Amino Acid Sequence
  • Animals
  • Anti-Bacterial Agents (pharmacology)
  • Bacterial Proteins (genetics)
  • Drug Resistance, Bacterial (genetics)
  • Female
  • Mice
  • Mice, Inbred BALB C
  • Mice, Transgenic
  • Microbial Sensitivity Tests
  • Molecular Sequence Data
  • Neisseria meningitidis (drug effects, genetics)
  • Phylogeny
  • Rifampin (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: